UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Uric acid: A marker of increased cardiovascular risk

Atherosclerosis, 2009-01, Vol.202 (1), p.11-17

2009

Volltextzugriff (PDF)

Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects

Atherosclerosis, 2015-01, Vol.238 (1), p.101-107

2015

Volltextzugriff (PDF)

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]

Journal of lipid research, 2014-12, Vol.55 (12), p.2509-2520

2014

Volltextzugriff (PDF)

Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

American journal of preventive cardiology, 2024-03, Vol.17, p.100611-100611, Article 100611

2024

Volltextzugriff (PDF)

Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography

Atherosclerosis, 2010-04, Vol.209 (2), p.481-486

2010

Volltextzugriff (PDF)

Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management

Progress in cardiovascular diseases, 2019-09, Vol.62 (5), p.414-422

2019

Volltextzugriff (PDF)

Improving risk stratification in people with previous manifestations of cardiovascular disease: one size does not fit all in secondary prevention

European journal of preventive cardiology, 2024-01, Vol.31 (2), p.216-217

2024

Volltextzugriff (PDF)

Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy

JACC. Cardiovascular imaging, 2019-09, Vol.12 (9), p.1797-1804

2019

Volltextzugriff (PDF)

The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?

Current atherosclerosis reports, 2021-08, Vol.23 (8), p.40-40, Article 40

2021

Volltextzugriff (PDF)

Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment

Current opinion in lipidology, 2019-04, Vol.30 (2), p.82-87

2019

Volltextzugriff (PDF)

Cardiovascular disease onset in old people with severe hypercholesterolemia

Atherosclerosis, 2023-01, Vol.365, p.9-14

2023

Volltextzugriff (PDF)

Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease

JACC. Cardiovascular imaging, 2020-04, Vol.13 (4), p.1090-1092

2020

Volltextzugriff (PDF)

Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter. The ELSA-Brasil

Atherosclerosis, 2018-10, Vol.277, p.273-277

2018

Volltextzugriff (PDF)

Familial hypercholesterolemia and cardiovascular disease in older individuals

Atherosclerosis, 2021-02, Vol.318, p.32-37

2021

Volltextzugriff (PDF)

Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype: What do genetic defects tell us and what are the clinical implications?

Atherosclerosis, 2017-08, Vol.263, p.316-317

2017

Volltextzugriff (PDF)

Vascular age derived from coronary artery calcium score on the risk stratification of individuals with heterozygous familial hypercholesterolaemia

European heart journal cardiovascular imaging, 2020-03, Vol.21 (3), p.251-257

2020

Volltextzugriff (PDF)

Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study

Atherosclerosis, 2017-08, Vol.263, p.393-397

2017

Volltextzugriff (PDF)

Pulse wave velocity—a useful tool for cardiovascular surveillance in pre-dialysis patients

Nephrology, dialysis, transplantation, 2007-12, Vol.22 (12), p.3527-3532

2007

Volltextzugriff (PDF)

Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil

Atherosclerosis, 2018-10, Vol.277, p.464-469

2018

Volltextzugriff (PDF)

Atorvastatin Treatment Improves Myocardial and Peripheral Blood Flow in Familial Hypercholesterolemia Subjects without Evidence of Coronary Atherosclerosis

Echocardiography (Mount Kisco, N.Y.), 2013-01, Vol.30 (1), p.64-71

2013

Volltextzugriff (PDF)

Fatty liver, inflamed blood and calcified coronary arteries: Lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al

Atherosclerosis, 2015-04, Vol.239 (2), p.634-636

2015

Volltextzugriff (PDF)

Peripheral arterial disease in heterozygous familial hypercholesterolemia

Atherosclerosis, 2015-09, Vol.242 (1), p.174-178

2015

Volltextzugriff (PDF)

Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia

Atherosclerosis, 2016-11, Vol.254, p.73-77

2016

Volltextzugriff (PDF)

Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein–deficiency states

Journal of clinical lipidology, 2008-08, Vol.2 (4), p.237-247

2008

Volltextzugriff (PDF)

1 – 25 von 56

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(53)
magazinearticle
(3)

Sprache

Englisch
(53)
Portugiesisch
(4)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(33)
Cardiovascular System & Cardiology
(29)
Female
(28)
Male
(27)
Cardiac & Cardiovascular Systems
(26)
Peripheral Vascular Disease
(22)
Adult
(21)
Atherosclerosis
(21)
Middle Aged
(21)
Familial Hypercholesterolemia
(19)
Risk Factors
(16)
Cardiovascular
(14)
Hyperlipoproteinemia Type Ii - Genetics
(13)
Aged
(10)
Biological And Medical Sciences
(9)
Medical Sciences
(9)
Hyperlipoproteinemia Type Ii - Blood
(8)
Hyperlipoproteinemia Type Ii - Complications
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Uric acid: A marker of increased cardiovascular risk

Familial hypercholesterolemia in Brazil: Cascade screening program, clinical and genetic aspects

Evaluation of clinical and laboratory parameters used in the identification of index cases for genetic screening of familial hypercholesterolemia in Brazil

Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome[S]

Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

Relation between visceral fat and coronary artery disease evaluated by multidetector computed tomography

Reducing cardiovascular risk in patients with familial hypercholesterolemia: Risk prediction and lipid management

Improving risk stratification in people with previous manifestations of cardiovascular disease: one size does not fit all in secondary prevention

Coronary Artery Calcium and Cardiovascular Events in Patients With Familial Hypercholesterolemia Receiving Standard Lipid-Lowering Therapy

The Role of RNA-Targeted Therapeutics to Reduce ASCVD Risk: What Have We Learned Recently?

Subclinical coronary atherosclerosis and cardiovascular risk stratification in heterozygous familial hypercholesterolemia patients undergoing statin treatment

Cardiovascular disease onset in old people with severe hypercholesterolemia

Absence of Coronary Artery Calcification in Middle-Aged Familial Hypercholesterolemia Patients Without Atherosclerotic Cardiovascular Disease

Familial hypercholesterolemia prevalence in an admixed racial society: Sex and race matter. The ELSA-Brasil

Familial hypercholesterolemia and cardiovascular disease in older individuals

Increased subclinical atherosclerosis burden in familial hypercholesterolemia phenotype: What do genetic defects tell us and what are the clinical implications?

Vascular age derived from coronary artery calcium score on the risk stratification of individuals with heterozygous familial hypercholesterolaemia

Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study

Pulse wave velocity—a useful tool for cardiovascular surveillance in pre-dialysis patients

Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil

Atorvastatin Treatment Improves Myocardial and Peripheral Blood Flow in Familial Hypercholesterolemia Subjects without Evidence of Coronary Atherosclerosis

Fatty liver, inflamed blood and calcified coronary arteries: Lessons and uncertainties from the multiethnic study of atherosclerosis -commentary on the study of Al Rifai et al

Peripheral arterial disease in heterozygous familial hypercholesterolemia

Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia

Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein–deficiency states

Suchergebnisse filtern